Business Wire

FPT to Become E.ON’s Strategic Partner for SAP Identity Management Managed Service

Share

FPT Europe, a subsidiary of the global technology services provider FPT Corporation, has become a strategic partner for E.ON Group in the area of digital transformation and SAP IDM Managed Services. According to the five-year contract, FPT will support E.ON on both legacy and new SAP environments at the corporate-wide level. The project will be delivered with FPT's best-shore model as SAP experts from FPT Germany (onsite), FPT Slovakia (nearshore) and the offshore delivery team in Vietnam will work together to assure the timely manner in responding to customer’s requests, provide excellent services with no communication barrier and time zone difference.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211103005041/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

F-Town 3 Campus of FPT Software (Photo: Business Wire)

Tailor-made services

Within the contract framework, FPT provides administration and maintenance of SAP functions in the Governance, Risk Management and Compliance (GRC) Operations. In addition, the IT experts manage user access authorizations through systematic User Authorization Management, develop and manage user roles as part of service Role Administration & Development. Moreover, FPT provides Security, Data Protection, Audit & Compliance Support as well as handles all related on-call Duty services.

By working with FPT, E.ON benefits from an optimized service delivery model and experienced technology experts who speak local language. The newly-signed contract also proves FPT’s outstanding service-level agreement which complies with the European General Data Protection Regulation.

FPT as a trusted partner in SAP for large enterprises

"In the course of the supplier consolidation and process optimization around SAP Identity @ Access Management, FPT was selected as our future supplier within the scope of a tender. The offer itself and the transition approach corresponded to what we as E.ON expect.

The operational topics of incident management and role building were awarded for a variety of SAP environments. Additional agreed services are in areas of audit and ICS/SOD support as well as application support for SAP IDM @ GRC Technology.

Past experience has shown that FPT has knowledge in most areas and is therefore also able to serve the E.ON world. The new topics were tackled quickly by FPT, and the transition phase is well progressed.

The aim is to have FPT on board as a reliable and SLA-loyal partner in this area from 01.11.2021. For the start of this managed service, we wish a lot of success, a motivated team and a good cooperation." summarized Dieter Bürgel, Head of Corporate Digital Services at E.ON the support engagement with FPT.

"This contract with E.ON demonstrates our ability to provide application managed services to large enterprises in Germany and Europe," said Le Hai, CEO of FPT Europe. "The key factor for success lies in the expertise and experience of our experts in SAP IDM Managed Services. We also effectively apply the best-shore model by combining our talent pools in Germany and Slovakia with the delivery team in Vietnam to achieve competitive advantages."

"We made great effort to find solutions to the difficulties encountered in preparing for this important contract," affirmed Andy Do, Deputy Director/ Head of Delivery at FPT Europe. "In particular, we invested early in recruiting experts for our Center of Excellence and trained our current employees to improve their SAP IDM Managed Services skills. And with all of this good preparation, we prove that FPT is able to meet the customer's high requirements and successfully win their trust."

About FPT Deutschland GmbH

Headquartered in Essen, Germany, FPT Deutschland GmbH is part of FPT Corporation, a technology and IT services provider headquartered in Vietnam with 36,000 employees and revenues of approximately $2 billion. As the pioneer in digital transformation, the company offers world-class services in smart factory, digital platforms, RPA (robotic process automation), artificial intelligence (AI), IoT (Internet of Thing), Data Analytics, Mobility, Cloud, Managed Services And Testing. FPT Software serves more than 700 customers worldwide, including 100 of which are Fortune 500 companies in the Aerospace, Automotive, Banking And Finance, Communications, Media And Services, Logistics And Transportation, Utilities, Consumer Products, Healthcare, Manufacturing, Public Sector, Technology, etc. Founded in 2012, FPT Europe is a technology partner of 50 leading companies, including RWE, Allianz, Siemens, Schaeffler, Airbus and Carlsberg,etc. For more information, visit: www.fpt-europe.de.

About E.ON

E.ON is a privately owned international energy company headquartered in Essen, Germany, that focuses on the business areas of energy networks and customer solutions. As one of the largest energy companies in Europe, E.ON plays a leading role in shaping a green, digital and decentralized energy world. Around 75,000 employees develop and sell products and solutions for residential, commercial and industrial customers. More than 50 million customers purchase electricity, gas, digital products or solutions for electromobility, energy efficiency and climate protection from E.ON. As an innovation leader, E.ON offers its customers the latest technology solutions and promotes cross-industry partnerships in the energy sector and beyond. More information at www.eon.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

FPT Deutschland GmbH
Linh Pham
Head of Marketing & Communications
LinhPTK@fsoft.com.vn

FPT Software Presseservice
Lewis Communications GmbH
+49 211 882 476 00
FPT_DE@teamlewis.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye